Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant Human Leptin Therapy Effects on Insulin Action

NCT01207934 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01207934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01207934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant Human Leptin Therapy Effects on Insulin Action
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
August 31, 1998
Completion date
July 31, 2000
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type two diabetes mellitus